Evidence map›Paper›PMID 42660988›Full record

ReviewNature reviews. Immunology2026

Immune-mediated excitotoxicity in brain disorders.

Josef Shin, Christina Francisca Vogelaar, Stefan Bittner, Frauke Zipp

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Josef ShinDepartment of Neurology, Research Center for Immunotherapy (FZI) and Focus Program Translational Neuroscience (FTN), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.ORCID http://orcid.org/0000-0002-3556-125X
Christina Francisca VogelaarDepartment of Neurology, Research Center for Immunotherapy (FZI) and Focus Program Translational Neuroscience (FTN), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.ORCID http://orcid.org/0000-0002-9683-7336
Stefan BittnerDepartment of Neurology, Research Center for Immunotherapy (FZI) and Focus Program Translational Neuroscience (FTN), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.ORCID http://orcid.org/0000-0003-2179-3655
Frauke ZippDepartment of Neurology, Research Center for Immunotherapy (FZI) and Focus Program Translational Neuroscience (FTN), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. zipp@uni-mainz.de.ORCID http://orcid.org/0000-0002-1231-1928

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Balanced activity of neuronal and immune networks is essential for maintaining central nervous system (CNS) function and mental health, whereas disturbances in network dynamics often lead to excitotoxicity and progressive pathology across brain diseases. Emerging evidence indicates that immune-mediated mechanisms can shape excitotoxic injury at least as profoundly as classical glutamatergic transmission. Here, we extend the concept of excitotoxicity beyond glutamate receptor overactivation to include innate and adaptive immune pathways, introducing the framework of immune-mediated excitotoxicity. We focus on three illustrative settings: epilepsy and ischaemic injury, where reiterative feedback between neuronal excitation and neuroimmune activation promotes acute excitotoxic damage; neurodegenerative disorders, in which misfolded protein aggregates act as immune stressors that amplify local inflammation; and multiple sclerosis, characterized by persistent, compartmentalized inflammation that drives chronic excitotoxic cycles. Across these examples, we define three hallmarks - feedback, stressor and chronicity - as organizing principles of this paradigm and describe the dynamic communication between neuronal and immune networks that underlies immune-mediated excitotoxicity. Recognizing these neuroimmune interactions as central to CNS homeostasis and - when perturbed - to disease opens up new avenues for therapeutic intervention targeting immune-mediated excitotoxicity.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.